According to the Centers for Disease Control and Prevention (CDC), Sepsis is the tenth most common cause of death overall in the U.S. Sadly, there is no commercially available test that actually detects the sepsis bacteria and current clinical protocols are simply a process of elimination.
mTrio is designed to both improve test compliance and reduce the rate of user error complications of diabetes that is attributed to being the single largest component of healthcare cost for the disease.
As diabetes care advances so does the demand for management systems capable of continuous monitoring of blood sugar levels with the seamless administration of insulin.
Pepex Biomedical develops an electrochemical biosensor platform for a blood glucose measuring system that connects wirelessly to the cloud, provides immediate diagnostic results, improves testing accuracy, and shares data with physicians, caregivers, and insurance providers.
